Response Rate and Prognostic Impact of Salvage Chemotherapy after Nivolumab in Patients with Advanced Gastric Cancer.
CONCLUSION: Our preliminary study indicates that nivolumab exposure may enhance subsequent chemosensitivity in patients with advanced gastric cancer.
PMID: 32428899 [PubMed - as supplied by publisher]
Source: Oncology - Category: Cancer & Oncology Authors: Arigami T, Matsushita D, Okubo K, Yanagita S, Ehi K, Sasaki K, Noda M, Kita Y, Mori S, Kurahara H, Uenosono Y, Ishigami S, Natsugoe S Tags: Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Study